Curis Inc
$ 0.68
9.57%
15 Apr - close price
- Market Cap 24,974,700 USD
- Current Price $ 0.68
- High / Low $ 0.79 / 0.60
- Stock P/E N/A
- Book Value 0.42
- EPS -0.58
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.67 %
- ROE -29.51 %
- 52 Week High 3.13
- 52 Week Low 0.49
About
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
Analyst Target Price
$14.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-20 | 2025-11-06 | 2025-08-05 | 2025-05-05 | 2025-03-31 | 2024-11-01 | 2024-08-01 | 2024-05-07 | 2024-02-08 | 2023-11-02 | 2023-08-03 | 2023-05-04 |
| Reported EPS | -0.4974 | -0.49 | -0.68 | -1.2538 | -1.25 | -1.7 | -2.03 | -2.05 | -2.03 | -2.13 | -0.12 | -0.12 |
| Estimated EPS | -0.4325 | -1.31 | -1.24 | -1.2633 | -0.99 | -1.84 | -1.67 | -2.12 | -2.11 | -2.33 | -0.12 | -0.1 |
| Surprise | -0.0649 | 0.82 | 0.56 | 0.0095 | -0.26 | 0.14 | -0.36 | 0.07 | 0.08 | 0.2 | 0 | -0.02 |
| Surprise Percentage | -15.0058% | 62.5954% | 45.1613% | 0.752% | -26.2626% | 7.6087% | -21.5569% | 3.3019% | 3.7915% | 8.5837% | 0% | -20% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.19 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CRIS
2026-04-11 01:40:15
Curis, Inc. (NASDAQ: CRIS) will hold its 2026 annual meeting virtually on May 19, 2026, where stockholders will vote on several proposals, including the election of two Class III directors and an increase in the number of authorized common stock shares. The board recommends voting "FOR" all proposals. The proxy materials delineate corporate governance, executive and director compensation, details of recent financing activities, and the rationale behind seeking authorization for additional shares to ensure financial flexibility.
2026-04-07 20:09:04
Nantahala Capital Partners LP has reported a beneficial ownership of 2.94 million shares, representing a 6.98% stake in Curis, Inc. (CRIS), as of March 31, 2026. This ownership includes 2.21 million shares exercisable within sixty days. The filing, a Schedule 13G, indicates shared voting and dispositive power over these shares and is considered to have a neutral impact and sentiment.
2026-04-07 20:09:04
Nantahala Capital Management, LLC, along with managers Wilmot B. Harkey and Daniel Mack, has reported beneficial ownership of 4,215,165 shares of Curis Common Stock (NASDAQ: CRIS) as of March 31, 2026. This stake represents 9.99% of the class, based on 2,215,165 shares outstanding cited from a previous Form 10-K. The filing indicates shared voting and dispositive power over these shares, held by funds and separately managed accounts under Nantahala's control.
2026-04-05 00:09:26
This analysis of Curis Inc (CRIS) in 2026 suggests it is not a strong buy for long-term beginner investors due to weak financial performance, bearish technical indicators, and a lack of positive catalysts. Despite a slight chance of short-term gains, the overall fundamentals are poor. Analysts' price targets for other companies in the sector indicate cautious optimism but also highlight risks from potential ACA and Medicare changes.
2026-04-02 09:09:57
Curis INC director Kenneth I. Kaitin recently purchased 10,000 shares of the company's common stock for $5,487, with the stock trading near its 52-week low. This purchase increases his direct ownership to 11,407 shares. The company is set to report earnings soon, following a significant financial turnaround in Q4 2025 due to a one-time gain from royalty rights sales.
2026-04-01 12:10:29
Kenneth I Kaitin, a director at Curis INC (NASDAQ: CRIS), recently invested $5,487 by purchasing 10,000 shares at $0.5487 each on March 31, 2026. This transaction occurred with the stock trading near its 52-week low after a significant year-long decline. The company is set to report earnings the next day, April 2nd, following a strong Q4 2025 net income driven by a one-time gain.
